CNTN

Tharimmune Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Tharimmune Inc is a biotechnology company developing targeted immunotherapies to combat inflammatory and autoimmune diseases.

$ 3.40
0.15 %

Tharimmune Inc

$ 3.40
0.15 %
CNTN

Tharimmune Inc is a biotechnology company developing targeted immunotherapies to combat inflammatory and autoimmune diseases.

Price history of Tharimmune Inc
Price history of Tharimmune Inc

Performance & Momentum

6 Months 10.19 %
1 Year 182.57 %
3 Years 98.92 %
5 Years 99.68 %

Strategic Analysis

Tharimmune Inc • 2026

Tharimmune Inc is positioned as a research-stage biotechnology company specializing in targeted immunotherapies for inflammatory and autoimmune diseases. Its profile is built on a niche investment case with strong scientific potential, with value essentially tied to the progress of its pipeline and its ability to turn research findings into credible clinical assets.

Strengths
  • Exposure to an attractive therapeutic segment, where unmet medical needs remain significant and opportunities for clinically meaningful differentiation are substantial
  • Specialized positioning in targeted immunotherapies, which may offer a more defensive value angle than more generalized biotech companies
  • Recent momentum has clearly improved, suggesting a renewed market interest in the story
Weaknesses
  • High dependence on clinical and regulatory execution, with the typical binary risk profile of small-cap biotech companies
  • Very weak long-term stock market track record, reflecting significant value destruction and still-fragile market confidence
Momentum

Momentum has turned favorable again in the short and medium term, indicating an improvement in sentiment around the stock after a long period of underperformance. For an investor, this points more to a speculative opportunity tied to the pipeline than to a firmly established trend, with genuine upside potential but one that remains dependent on convincing scientific or clinical progress.

Similar stocks to Tharimmune Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone